| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/21/2002 | WO2002014855A1 Wide-range toc instrument using plasma oxidation |
| 02/21/2002 | WO2002014850A1 A process and device for continuous ionic monitoring of aqueous solutions |
| 02/21/2002 | WO2002014836A2 Apparatus and methods for measuring extensional rheological properties of a material |
| 02/21/2002 | WO2002014835A1 Method for evaluating creep lifetime |
| 02/21/2002 | WO2002014833A1 Support device for a preparation for the separation of individual objects from the preparation by means of laser irradiation |
| 02/21/2002 | WO2002014832A1 Method and device for sampling and storing urine specimen |
| 02/21/2002 | WO2002014831A2 Inflatable mannequin and system for thermal property measurement and associated methods |
| 02/21/2002 | WO2002014830A2 Method of identification and quantification of biological molecules and apparatus therefore |
| 02/21/2002 | WO2002014557A1 Diagnosis and treatment of tumor-suppressor associated disorders |
| 02/21/2002 | WO2002014555A2 Single-labeled oligonucleotide probes |
| 02/21/2002 | WO2002014554A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| 02/21/2002 | WO2002014546A1 Use of microbial dna sequences for the identification of human diseases |
| 02/21/2002 | WO2002014545A2 Method for determining weather a test compound binds to a large rna target |
| 02/21/2002 | WO2002014543A2 Process for detecting enzyme activity in an immunoassay |
| 02/21/2002 | WO2002014542A2 Process for detecting serine/threonine kinase activity |
| 02/21/2002 | WO2002014541A1 Method of examining infection with helicobacter pylori and diagnostic kit |
| 02/21/2002 | WO2002014539A1 Bioreactor and bioprocessing technique |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014535A2 Electrochemical strip test for small volumes |
| 02/21/2002 | WO2002014533A2 Creatinine sensor calibration |
| 02/21/2002 | WO2002014532A2 Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10 |
| 02/21/2002 | WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | WO2002014516A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014500A2 Human genes and gene expression products |
| 02/21/2002 | WO2002014499A2 Claudin polypeptides |
| 02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | WO2002014485A2 Kallikrein gene |
| 02/21/2002 | WO2002014475A2 QUANTITATIVE ASSESSMENT OF erbB/HER RECEPTORS IN BIOLOGICAL FLUIDS |
| 02/21/2002 | WO2002014467A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 02/21/2002 | WO2002014462A1 Biosensors and methods for their use |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014361A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014353A1 Anti-heparin peptides |
| 02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
| 02/21/2002 | WO2002014290A1 Lipo- or amphiphilic scintillators and their use in assays |
| 02/21/2002 | WO2002013961A2 Chemical screening system using strip arrays |
| 02/21/2002 | WO2002013848A1 Highly homogeneous molecular markers for electrophoresis |
| 02/21/2002 | WO2002013781A1 Method for preparation of chewing gum with customer acceptable taste |
| 02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | WO2002013685A1 Diagnostic device for distinguishing between normal and ectopic pregnancy and method for preparing the same |
| 02/21/2002 | WO2002013598A2 Fish hatching method and apparatus |
| 02/21/2002 | WO2001087832A3 System and method for carbohydrate sequence presentation, comparison and analysis |
| 02/21/2002 | WO2001081890A3 Hydrogel biosensor and biosensor-based health alarm system |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001079830A3 A system and method to determine thermophysical properties of multi-component gas |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001077140A3 Measurement of nutrient uptake in cells and methods based thereon |
| 02/21/2002 | WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | WO2001071347A8 Method and apparatus for predicting ligand binding interactions |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001069227A3 Ion-sensitive microelectrodes |
| 02/21/2002 | WO2001068899A3 Molecular weight markers for western blot |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001061352A3 Production of a protein biosensor with a defined binding matrix |
| 02/21/2002 | WO2001059110A3 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001057537A3 Methods for diagnosis of alzheimer's disease |
| 02/21/2002 | WO2001057535A3 Analytical method to evaluate animal models of neurofibrillary degeneration |
| 02/21/2002 | WO2001057510A3 Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| 02/21/2002 | WO2001057198A3 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001053532A3 Barcoded synthetic lethal screening to identify drug targets |
| 02/21/2002 | WO2001053338A3 Cbp86, a sperm specific protein |
| 02/21/2002 | WO2001051926A3 Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens |
| 02/21/2002 | WO2001051629A3 Circularly permutated, interaction-activated proteins |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001046698A3 Tethered ligands and methods of use |
| 02/21/2002 | WO2001046397A3 Human kinases |
| 02/21/2002 | WO2001044511A3 Methods and compositions for detection of mycobacterium avium complex species |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001044205A3 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 02/21/2002 | WO2001043870A3 Column and row addressable high density biochip array |
| 02/21/2002 | WO2001040802A3 Novel protein |
| 02/21/2002 | WO2001035071A3 Cell analysis and sorting apparatus for manipulation of cells |
| 02/21/2002 | WO2001031566A3 Apparatus and methods for verifying the location of areas of interest within a sample in an imaging system |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001030967A3 Fluorescent cobalamins and uses thereof |
| 02/21/2002 | WO2001027624A3 Compositions and methods for detecting protein modification and enzymatic activity |
| 02/21/2002 | WO2001023605A3 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 02/21/2002 | WO2001020326A3 Materials and methods for the determination of an analyte |
| 02/21/2002 | WO2001018524A3 Methods for improving signal detection from an array |
| 02/21/2002 | WO2000075662A9 Cell-signaling assays |
| 02/21/2002 | WO2000073797A9 Homogeneous tests for sequentially determining lipoprotein fractions |
| 02/21/2002 | WO2000067737A9 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION |
| 02/21/2002 | WO2000065347A9 Multiple diagnostic device for a woman's health |
| 02/21/2002 | WO2000062036A9 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
| 02/21/2002 | WO2000060125A3 High resolution dna detection methods and devices |
| 02/21/2002 | US20020023281 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020023280 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020022933 Chemical structure identification |
| 02/21/2002 | US20020022932 Apparatus for evaluating activity of catalysts |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022717 Using monoclonal antibodies |
| 02/21/2002 | US20020022716 Detecting modulator of protein activity; mix modulator and target protein complex, incubate with enzyme and substrate, measure enzyme activity, adjustment in activity indicates modulator |
| 02/21/2002 | US20020022599 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/21/2002 | US20020022594 Overcoming Bcl-2 apoptosis resistance; administering a compound with calpain activity to cleave Bax to produce a Bax/p18 protein fragment |
| 02/21/2002 | US20020022276 Individually addressable micro-electromagnetic unit array chips |
| 02/21/2002 | US20020022275 Cloning and copying on surfaces |